Hemospan (MP4OX)

DRUG5 trials

Sponsors

Sangart

Conditions

Blood Loss, SurgicalCritical Lower Limb IschemiaHypotensionHypoxiaIschemiaProstate CancerSurgeryVascular Disease

Phase 1

Increasing Dose Safety Study of Hemospan in Orthopedic Surgery Patients

CompletedNCT00494949

SangartHypotension, Hypoxia

Start: 2003-04-30End: 2006-08-31Updated: 2013-08-19

Phase 2

Safety Study of Hemospan® in Prostatectomy Patients

CompletedNCT00425334

SangartBlood Loss, Surgical, Prostate Cancer, Surgery

Start: 2005-07-31End: 2007-11-30Updated: 2013-08-19

Pilot Study of Hemospan® in Patients With Chronic Critical Limb Ischemia

CompletedNCT00633659

SangartCritical Lower Limb Ischemia, Vascular Disease

Start: 2007-09-30End: 2008-12-31Updated: 2013-08-19

Phase 3

Phase III Study of Hemospan® to Prevent Hypotension in Hip Arthroplasty

CompletedNCT00421200

SangartHypotension, Ischemia

Start: 2007-02-28End: 2008-06-30Updated: 2013-08-19

Phase III Study of Hemospan® for Treating Hypotension in Hip Arthroplasty

CompletedNCT00420277

SangartHypotension, Ischemia

Start: 2007-02-28End: 2008-04-30Updated: 2013-08-19